Abstract

<div>Abstract<p>Deubiquitinating enzymes are increasingly recognized to play important roles in cancer, with many acting as oncogenes or tumor suppressors. In this study, we employed a bioinformatics approach to screen for enzymes from this family involved in cancer and found <i>USP24</i> as a potent predictor of poor outcomes in neuroblastoma, an aggressive childhood cancer. <i>USP24</i> resides in a region commonly deleted in neuroblastoma, yet was independently associated with poor outcomes in this disease. Deletion of <i>Usp24</i> in a murine model resulted in degradation of collapsin response mediator protein 2 (CRMP2), a regulator of axon growth, guidance, and neuronal polarity. Cells lacking USP24 had significant increases in spindle defects, chromosome missegregation, and aneuploidy, phenotypes that were rescued by the restoration of CRMP2. USP24 prevented aneuploidy by maintaining spindle-associated CRMP2, which is required for mitotic accuracy. Our findings further indicate that <i>USP24</i> is a tumor suppressor that may play an important role in the pathogenesis of neuroblastoma.</p>Significance:<p>This study identifies the chromosome instability gene <i>USP24</i> as frequently deleted in neuroblastoma and provides important insight into the pathogenesis of this aggressive childhood cancer.</p></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.